LeonaBio (LONA)
NASDAQ:LONA
Total Valuation
LeonaBio has a market cap or net worth of $91.02M. The enterprise value is -$30.26M.
Market Cap$91.02M
Enterprise Value-$30.26M
Share Statistics
LeonaBio has 9,393,514 shares outstanding. The number of shares has decreased by -2.65% in one year.
Shares Outstanding9,393,514
Owned by Insiders―
Owned by Institutions―
Financial Efficiency
LeonaBio’s return on equity (ROE) is -3.80 and return on invested capital (ROIC) is -226.69%.
Return on Equity (ROE)-3.80
Return on Assets (ROA)-1.15
Return on Invested Capital (ROIC)-226.69%
Return on Capital Employed (ROCE)-2.29
Revenue Per Employee0.00
Profits Per Employee-4.06M
Employee Count26
Asset Turnover0.00
Inventory Turnover0.00
Valuation Ratios
The current PE Ratio of LeonaBio is ―. LeonaBio’s PEG ratio is 0.15.
PE Ratio―
PS Ratio0.00
PB Ratio1.16
Price to Fair Value1.16
Price to FCF-0.71
Price to Operating Cash Flow-0.91
PEG Ratio0.15
Income Statement
In the last 12 months, LeonaBio had revenue of 0.00 and earned -105.61M in profits. Earnings per share was -24.70.
Revenue0.00
Gross Profit-68.09M
Operating Income-102.27M
Pretax Income-105.61M
Net Income-105.61M
EBITDA-102.27M
Earnings Per Share (EPS)-24.70
Cash Flow
In the last 12 months, operating cash flow was -45.73M and capital expenditures 0.00, giving a free cash flow of -45.73M billion.
Operating Cash Flow-45.73M
Free Cash Flow-45.73M
Free Cash Flow per Share-4.87
Dividends & Yields
LeonaBio pays an annual dividend of ―, resulting in a dividend yield of ―
Dividend Per Share―
Dividend Yield―
Payout RatioN/A
Free Cash Flow Yield―
Earnings Yield―
Stock Price Statistics
Beta1.98
52-Week Price Change272.69%
50-Day Moving Average7.11
200-Day Moving Average5.13
Relative Strength Index (RSI)54.61
Average Volume (3m)41.47K
Important Dates
LeonaBio upcoming earnings date is May 7, 2026, After Close (Confirmed).
Last Earnings DateMar 26, 2026
Next Earnings DateMay 7, 2026
Ex-Dividend Date―
Financial Position
LeonaBio as a current ratio of 1.88, with Debt / Equity ratio of 2.89%
Current Ratio1.88
Quick Ratio1.88
Debt to Market Cap0.02
Net Debt to EBITDA0.67
Interest Coverage Ratio0.00
Taxes
In the past 12 months, LeonaBio has paid 0.00 in taxes.
Income Tax0.00
Effective Tax Rate0.00
Enterprise Valuation
LeonaBio EV to EBITDA ratio is 0.35, with an EV/FCF ratio of 0.79.
EV to Sales0.00
EV to EBITDA0.35
EV to Free Cash Flow0.79
EV to Operating Cash Flow0.79
Balance Sheet
LeonaBio has $88.33M in cash and marketable securities with $803.00K in debt, giving a net cash position of $87.53M billion.
Cash & Marketable Securities$88.33M
Total Debt$803.00K
Net Cash$87.53M
Net Cash Per Share$9.32
Tangible Book Value Per Share$6.50
Margins
Gross margin is 0.00%, with operating margin of 0.00%, and net profit margin of 0.00%.
Gross Margin0.00%
Operating Margin0.00%
Pretax Margin0.00%
Net Profit Margin0.00%
EBITDA Margin0.00%
EBIT Margin0.00%
Analyst Forecast
The average price target for LeonaBio is $16.00, which is 11.43% higher than the current price. The consensus rating is Moderate Buy
Price Target$16.00
Price Target Upside65.12% Upside
Analyst ConsensusModerate Buy
Analyst Count2
Revenue Growth Forecast―
EPS Growth Forecast66.10%